Biomarker can help predict preeclampsia risk in women with sickle cell disease
(WASHINGTON — October 21, 2025) – In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring levels of a protein associated with placental function and development. These findings provide insight that may help clinicians to anticipate and mitigate adverse pregnancy outcomes and were published in the journal Blood Advances.
“Patients with sickle cell disease are at high risk for developing preeclampsia, but the challenge is that these patients ...